Medium-chain fatty acids accumulating in MCAD deficiency elicit lipid and protein oxidative damage and decrease...

Area of Science:

• Biochemistry
• Neuroscience
• Metabolic Disorders

Background:

• Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is a common inherited metabolic disorder affecting fatty acid oxidation.
• Patients with MCADD accumulate medium-chain fatty acids like octanoate (OA) and decanoate (DA), leading to severe neurological complications.

Purpose of the Study:

• To investigate the in vitro effects of OA and DA on oxidative stress in rat cerebral cortex homogenates.
• To elucidate the role of these accumulating fatty acids in the pathophysiology of MCADD-related neurological symptoms.

Main Methods:

• Incubation of rat cerebral cortex homogenates with OA and DA.
• Measurement of oxidative stress markers: chemiluminescence, lipoperoxidation (TBARS), total antioxidant capacity, protein damage (carbonyl content, sulfhydryl oxidation), and reduced glutathione (GSH) levels.
• Fractionation of homogenates to investigate subcellular mechanisms (cytosolic vs. mitochondrial).

Main Results:

• Both OA and DA significantly increased lipoperoxidation and decreased total antioxidant capacity.
• DA exposure led to increased protein damage (carbonyl content, sulfhydryl oxidation) and reduced GSH levels.
• DA-induced GSH depletion and sulfhydryl oxidation were localized to mitochondria, suggesting a mitochondrial mechanism.

Conclusions:

• Accumulating medium-chain fatty acids (OA and DA) in MCADD induce significant oxidative stress in the rat brain.
• Mitochondrial dysfunction appears to play a key role in the mechanism of DA-induced oxidative damage.
• These findings suggest that oxidative stress is a potential pathomechanism underlying the neurological manifestations of MCADD.